.jpg)
.png)
All
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha® (evolocumab) to include adults at increased risk for major adverse cardiovascular events (MACE) due to... more
Atherosclerosis occurs due to a complex interaction between dyslipidemia and proinflammatory molecules.(1) It is the key culprit for globally prevalent cardiovascular diseases (CVD). Vascular inflammation may lead to atherosclerotic plaque rupture, thrombus formation, and subsequent occlusion,... more
Nutrition & Lifestyle Workgroup discussion items can go here. Note that these posts are visible to the general public.
A decade ago, the lipid community was eagerly awaiting the completion of Phase III trials of torcetrapib, the first- in-class of the cholesteryl ester transfer protein (CETP) inhibitors. Given the epidemiological assumptions that every 1.0 mg/dL increase in high-density lipoprotein cholesterol... more
Introduction Most diabetes care occurs in a primary care setting. Standards of diabetes care from several professional organizations include setting specific lipid goals for diabetic patients. Recommendations include medication and lifestyle changes to achieve lipid and glucose goals. Several... more
The National Lipid Association (NLA) assembled a panel of experts to update its guidance for the use of proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody therapy made in the NLA Recommendations for Patient-Centered Management of Dyslipidemia: Part 2 in 2015.
Lipid Management in Specific Populations, the theme for this edition of LipidSpin, is a culmination of what Dr. Chima Nwizu, SWLA President, and I believe moves our organization forward. The National Lipid Association realizes the importance of understanding, investigating, and advocating treatment... more
Introduction Individuals with diabetes have an increased risk of morbidity and mortality related to cardiovascular disease,1 accounting for 44 percent of deaths in patients with type 1 diabetes mellitus and 57 percent of deaths in patients with type 2 diabetes mellitus.2 Although youth with... more
Join us for our virtual business meeting! On behalf of the National Lipid Association, the 2020 Annual Business Meeting will be held electronically Monday, June 8, 2020 from 6:00-6:30 PM ET. Agenda: President’s Introduction Secretary / Treasurer’s Report Nominating... more
There is a large population >80 in the U.S., some who have either been advised to or chose to discontinue statin therapy. Randomized clinical trials have typically excluded very elderly subjects or group all elderly into age >65. There are vast differences in this population in terms of... more